| 000 | 01522 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515005853.0 | ||
| 264 | 0 | _c20070111 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1165-158X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhmad, M | |
| 245 | 0 | 0 |
_aHeme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. _h[electronic resource] |
| 260 |
_bCellular and molecular biology (Noisy-le-Grand, France) _cSep 2005 |
||
| 300 |
_a371-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xchemically induced |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xenzymology |
| 650 | 0 | 4 |
_aEndothelial Cells _xenzymology |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
| 650 | 0 | 4 |
_aHeme Oxygenase (Decyclizing) _xmetabolism |
| 650 | 0 | 4 |
_aHeme Oxygenase-1 _xgenetics |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
| 650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aStreptozocin _xpharmacology |
| 650 | 0 | 4 |
_aVasodilation _xgenetics |
| 700 | 1 | _aTurkseven, S | |
| 700 | 1 | _aMingone, C J | |
| 700 | 1 | _aGupte, S A | |
| 700 | 1 | _aWolin, M S | |
| 700 | 1 | _aAbraham, N G | |
| 773 | 0 |
_tCellular and molecular biology (Noisy-le-Grand, France) _gvol. 51 _gno. 4 _gp. 371-6 |
|
| 999 |
_c15932633 _d15932633 |
||